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ABSTRACT 
 
        Recently scientists are interested in developing new variants of red fluorescent proteins 
(RFPs), because biosensors basing on RFPs show visual superiority in live-cell imaging. In this 
thesis, the structures of two RFP variants, K78BoF and mRuby0.4-3, were investigated by X-ray 
crystallography. A monomeric crystal structure of K78BoF was obtained at pH 6 with resolution 
at 2.13Å, while a dimeric crystal structure of mRuby0.4-3 was determined at pH 8.2 with 
resolution at 2.63Å. Both of their chromophores are formed by Met-Tyr-Gly with K78BoF in the 
cis state and mRuby0.4-3 in trans. Hydrogen bonds connecting water molecules and residues to 
K78BoF chromophore probably stabilize the conformation of the chromophore and contribute to 
the red fluorescence emitted. However, the substitution of an unnatural amino acid p-
boronophenylalanine breaks two hydrogen bonds, causing a deviation of the conformation. 
Analysis of hydrogen bonds on mRuby0.4-3 chromophore was limited by the relatively low 
resolution of the crystal.  
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BACKGROUND AND INTRODUCTION 
 
1. Naturally existing fluorescent proteins 
        As a starting point for the history of scientific research on fluorescent proteins (FPs), in 
1962, Osamu Shimomura discovered and isolated a green FP (GFP), avGFP from jellyfish 
Aequorea Victoria, as a companion protein to a photoprotein named aequorin 1. Later he and his 
research group clarified the relationship between these two proteins, that aequorin can be 
triggered by Ca2+ to emit a blue light with maximum emission wavelength (lmax) at 460nm 
which avGFP will then absorb at 400 and 480nm followed with reemitting the absorbed energy 
as green fluorescence with lmax at 509nm 2. In 1979, he also deduced the structure of the 
chromophore for avGFP through synthesizing small model molecules and comparing them with 
the chromophore isolated from a papain digest of heat-denatured avGFP; in this period NMR had 
not yet been developed for structure determination 3. His deduction was confirmed later. 
Although avGFP was successfully crystallized in 1974 4 and the x-ray diffraction patterns were 
reported in 1988 5, the 3D structure was not solved until 1996, reported separately by Ormö et al 
6 and Yang et al 7. avGFP (PDB 1EMA) is composed of an 11-stranded β-barrel threaded by an α
-helix running up the axis of the cylinder, and a chromophore is attached to the α-helix and 
buried almost perfectly in the center of the cylinder (Fig. 1A).  
        Early research and the crystal structure proved that avGFP chromophore is formed by 
intramolecular cyclization of Ser65-Tyr66-Gly67 (Fig. 1B) 8.  Then in 1994, Roger Tsien’s 
group expressed avGFP in E. coli cells and found that development of fluorescence from avGFP 
required participation of oxygen without enzymes or cofactors involved, which was confirmed 
through blocking fresh protein synthesis by puromycin and tetracycline and controlling the 
admission of air. A hypothesis of the mechanism for the formation of the chromophore was 
proposed by the group, as shown in Fig. 2 9. To improve its fluorescence properties, Tsien and 
his collaborators developed multiple mutants with brighter fluorescence and different colors 
including yellow, cyan and blue, which will be discussed with details later here.  
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A   B  
Fig. 1 Structures of green fluorescent protein (PDB 1EMA) (A) and its chromophore (B) 
isolated from A. Victoria 11.  
 
 
Fig. 2 Proposed biosynthetic scheme for the chromophore of avGFP 9. 
cyclization 
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        Almost at the same time as Tsien’s work, Martin Chalfie et al successfully inserted the 
avGFP gene into Caenorhabditis elegans cells and expressed the protein in the first stage C. 
elegans larva without losing the green fluorescence 10. It showed no cytotoxic effects to the cells 
in the experiment, which was a milestone for the application of FPs on monitoring gene 
expression and protein localization in not only prokaryotic but also eukaryotic organisms. In 
2008, Osamu Shimomura, Roger Tsien and Martin Chalfie shared the Nobel Prize in Chemistry 
for their contributions in the discovery and applications of fluorescent proteins.  
        Wild-type GFP is commonly considered to be the one from A. Victoria, but a number of 
naturally existing GFPs have also been discovered in other species classified in phylum Cnidaria, 
such as jellyfishes Mitrocoma, Obelia and Phialidium in class Hydrozoa, sea cactus 
Cavernularia, sea pansy Renilla and sea pen Ptilosarcus and Pennatula in class Anthozoa 12. 
Later family Pontellidae in phylum Arthropoda 13, 14 and amphioxus in phylum Cephalochordates 
15 were also reported to express green FPs. All of them share the same chromophore structure as 
avGFP with moderate differences in maximum excitation and emission wavelengths, which can 
be a result from modification of the chemical environment surrounding the chromophore 16-19. 
Some GFP-like proteins in these phyla were also found but lack fluorescence 20-22. For that the 
species expressing GFP-like proteins located distantly on phylogenetic tree, it raises an 
interesting research topic to scientists in evolutionary ecology, the diversity and evolution of the 
GFP family. The production of GFPs, including avGFP, in organisms is generally considered for 
warning, defense of predator or attraction of prey, while some other functions like 
photoprotection and protective antioxidation have also been claimed recently. Despite of this, the 
genes encoding GFPs in different species, especially for the ones coming from different phyla, 
share little similarity, making it hard to conclude if they originate from a common ancestor or not 
23. With more and more species producing GFPs or GFP-like proteins being discovered and 
investigated, more clues may be obtained to help answer this question. 
        FPs emitting other colors have also been discovered in nature. Because they all share the 
11-stranded β-barrel structure common to GFPs, all of them belong to the family of GFP-like 
proteins. Including GFPs, FPs are usually separated into four groups, according to the color 
difference in human eyes: purple-blue, green, yellow, and orange-red.  
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        So far, over 23 species of GFPs has been isolated that share the same chromophore 
structure. Despite that most emit green fluorescence upon excitation with lmax at 500-520nm, the 
subtle difference of the chemical environment surrounding the chromophore affects the 
excitation and emission wavelengths of the proteins, causing obvious deviation of the color 
emitted 16. For example, dsFP483 from Discosoma striata is green in the ground state, yet it 
turns into cyan with lmax at 484nm when it is excited. According to its 2.1Å crystal structure, it 
shares the same cis-coplanar chromophore with avGFP, while the phenolic hydroxyl of its 
chromophore interacts with Ser146, a water molecule and the imidazole ring of His163 by 
hydrogen bonds, probably allowing a self-protonation equilibrium that results in blue-shifting 24. 
The other cyan FP (CFP) amFP486 from Anemonia majana blue-shifting to 486nm could be a 
consequence of localizing chromophore charge density on the phenolate moiety through 
interactions between the chromophore and side chains of Ala165 and His199 25.  
        Unlike GFPs that are found in diverse species, all other three groups of FPs are only found 
in limited species of Hydrozoa and Anthozoa. Until now, only one naturally existing yellow FP 
(YFP) has been reported. zFP538 is a tetramer YFP isolated from Zoanthus sp. with a unique 
three-ring chromophore (Fig. 3a). After Tyr67 and Gly68 form a two-ring structure similar to the 
GFP chromophore, the side chain of Lys66 is cyclized into a new six-member ring with a 
cleavage of the peptide backbone between position 65 and 66. An extra C=C bond extends the π-
conjugated system and shifts lmax to 539nm 26, 27. 
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a   b  
c   d        
e    
Fig. 3 Structures of chromophores in naturally existed colored FPs. They are zFP538 (a), 
dsRed (b), eqFP611 (c), asPF595 (d), Kaede, in green fluorescent form (left) and red fluorescent 
form (right) (e). 
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        In 1999, Matz et al successfully cloned the first red FP (RFP), DsRed, from coral 
Discosoma sp. 27. Then in 2000, its crystal structure and chromophore structure (Fig. 3b) were 
solved by Wall et al 28 and Gross et al 29 respectively. Dehydrogenation between α-carbon and 
nitrogen on Gln66 with catalysis by oxygen forms a N-acylimine structure connecting to the 
five-member ring cyclized by Tyr67 and Gly68, which introduces two more double bonds to the 
conjugated system and leads to red-shift of lmax to 583nm 29. Discovery of this protein later 
became a ground stone for developing a series of RFP variants commercially available. In 2002, 
eqFP611, emitting fluorescence in the far-red area on the scale, was isolated from the sea 
anemone Entacmaea quadricolor 30. A 2.0Å crystal structure shows the far-red light may come 
from contribution of a trans-coplanar chromophore constructed by Met63-Tyr64-Gly65 (Fig. 
3c), a parallel ring-stacking interaction with His197, and interaction with other surrounding 
residues 31. In 2004, Kusabira Orange (KO), also considered to be the first orange-color-emitting 
FP, was discovered in the stony coral Fungia concinna 32. Although its crystal structure has 
never been reported, the monomer variant mKO has been studied (Fig. 4a), and it is believed that 
Glu212 plays a key role in the formation of a five-membered thioamide ring by Cys65 on the 
chromophore 33. In 2007, another RFP from E. quadricolor, eqFP578, was cloned and found to 
share 76% homology in amino acid sequence with eqFP611, including the chromophore, but no 
crystal structure was solved for it 34. All these wild-type RFPs are parents of a number of RFP 
variants that have been applied in different fields.  
        Despite their construction by β-barrel and chromophore structures, it is hard to consider the 
GFP-like proteins in purple-blue color as FPs, because they do not emit fluorescence even 
though absorbance is observed 16. The chromophore of asPF595, a purple nonfluorescent protein 
isolated from Anemonia sulcota, is formed by the same three amino acid residues to eqFP611, 
but in a different structure with the backbone cut off, as shown in Fig. 3d 35. The chemical reason 
for their non-fluorescence and the biological function are still unknown.  
        Besides the above, it is worthy to mention that several GFPs display the property of 
photoconvertibility. Kaede, a GFP from Trachyphyllia geoffroyi, has a three-ring chromophore 
formed by His62-Tyr63-Gly64 (Fig. 3e), which can switch green fluorescence to red after 
exposing to UV light. It is achieved by a β-elimination reaction on Nα–Cα of His62 after being 
excited by UV and releasing the water molecule binding to the His62 imidazole ring, which 
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prolongs the π-conjugated system and leads to red-shifting 36, 37. EosFP from Lobophyllia 
hemprichii 38, Dendra from Dendronephthya sp. 39 and KikG from Favia favia 40 also show 
similar ability under UV or blue illumination. The case of Dronpa, a GFP isolated from 
Pectiniidae sp., is a little bit different because it changes between fluorescence and non-
fluorescence through irradiation with UV and blue lights 41. This property has not been 
discovered in FPs with other colors until now.  
        So far as has been reported, all chromophores in wild-type FPs are generated by 
autocatalytic modification between three continuous amino acids in a Xxx-Tyr-Gly template, as 
shown in Table 1. The cyclization between Tyr and Gly makes them share a same imidazolinone 
core and a mutual π-conjugated system with excited-state energy levels located in the visible 
light spectrum 42, while the identity of the first amino acid plays a dominant role in the color of 
fluorescence produced. The chemical properties of the side chain and the further modification 
after the imidazolinone is formed may increase the length of the conjugation chain, pushing the 
excitation and emission wavelengths to the red area of the visible spectrum. One more double 
bond on the GFP chromophore would convert it into YFP. Meanwhile, interaction between the 
chromophore and amino acid residues on the β-barrel, water molecules and/or solvent molecules, 
may greatly influence the fluorescence as well. With an identical chromophore structure under 
different chemical environments, amFP486, dsFP483 and cFP484 emit cyan light when avGFP 
emits green, KO looks orange while Dronpa switches between green and red.  
        
Table 1 Selected FPs and the amino acid residues forming chromophores. 
Selected FPs Residues forming chromophores 
avGFP, amFP486, dsFP483, cFP484 Ser-Tyr-Gly 
zFP538 Lys-Tyr-Gly 
DsRed Gln-Tyr-Gly 
eqFP578, eqFP611, asFP595  Met-Tyr-Gly 
KO, Dronpa Cys-Tyr-Gly 
Kaede, EosFP His-Tyr-Gly 
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2. Development of FP variants 
        It was fortunate to discover avGFP first, because it has multiple strengths favoring the 
applications for scientists. It is non-toxic to any organism, easily fused to proteins, expressed and 
tracked in vivo. Also, it naturally forms into a weak dimer with a small mass (~50kD), allowing 
the avGFP-labeled protein to keep the original structure and function. Its ease-of-use helped the 
FP technology to develop with great interest. However, unlike avGFP, most wild-type FPs exist 
as obligate tetramers, whose large size prohibits them to be fusion tags for proteins. Some of 
them show poor brightness and/or stability in vivo, and are found lethal to living cells. Moreover, 
the issues with slow folding and incomplete formation of chromophores commonly exist in wild-
type FPs. Baird et al reported that DsRed took about 27 hours to reach half its maximum red 
fluorescence at room temperature, and more than 48 hours to be maximum; a certain amount of 
green fluorescence was detected during the formation of the chromophore, implying an 
incomplete maturation 43. Considering the huge potential in FP application as research tools, 
scientists are making efforts to overcome the limitations through developing FP variants with 
multiple bioengineering methods including random mutagenesis by chemical mutagens, error-
prone PCR, deliberate site-directed mutations, randomization of a predetermined stretch of 
amino acids, DNA shuffling, heteroduplex recombination, directed evolution 12.   
        Another motivation to develop FP variants is that fluorescence emitted by all reported wild-
type FPs has maxima in limited wavelength ranges, leaving obvious gaps in the spectrum.  
Though searching new FPs is still under process, it is time-consuming and sometimes it needs 
some luck. To not only seek better research tools in a faster manner but also satisfy curiosity 
from scientists, filling the empty space on the spectrum via manipulating protein structures can 
be a more accessible direction.  
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a  b     
c        d   
e  
f    
Fig. 4 Structures of chromophores in FP variants. They are mKO (a), mOrange (b), EBFP (c), 
ECFP (d), EGFP (e), TagBFP (f) in the blue form (left) and the red form (right). 
	 10	
        Currently the mutation research mainly focuses on three strategies: introducing amino acids 
to the positions connecting molecules to interrupt formation of tetramer, manipulating the 
chromophore structure and/or the residues on the β-barrel to improve quality of FPs for favoring 
the application. They may be applied solely or together. Now a lot of FP variants have been 
generated.  
        As the first FP discovered, mutants of avGFP were investigated much earlier than other 
wild-type FPs. Plenty of variants have been generated, and some of them are serving as 
important tools in labs. In 1995, Heim et al replaced Ser65 with Thr in the chromophore, and the 
variant showed strikingly less chromophore-forming time without obvious shift of excitation 
wavelength 44. To keep this advantage and increase the brightness, mutation F64L was further 
executed by Cormack et al, and EGFP emitting 35-fold brighter fluorescence than avGFP was 
created (Fig. 4e) 45. With further substitution of Thr203 to Tyr or His, the protein emitted yellow 
fluorescence, probably because the polar aromatic residues could lower the excited-state energy 
of the adjacent chromophore 46. When mutation happened to Tyr66 instead of Ser65, the change 
was also dramatic. The exchange of Tyr66 to Trp introduced an indole in the chromophore, blue-
shifting lmax from 508nm to 480nm with weak cyan fluorescence produced47. The further 
mutation of F64L/S65T/N146I/M153T/V163A generated a brighter version, ECFP (Fig. 4d) 48. 
Yet the replacement of Tyr66 with His could move the emission wavelength to further blue area 
with lmax at 448nm, emitting weak blue light 47. With replacement of F64L and Y145F, EBFP 
was created with improved brightness 48, 49. Because of their dim color and being easily 
photobleached, blue fluorescent proteins (BFPs) are less practical than other FP variants. 
Although the research is still ongoing, scientists realize that it is hard for GFPs to evolve into 
variants beyond yellow-green. Therefore, to produce red FP variants, the original species needed 
to be screened for RFPs.  
        Luckily, a number of wild-type RFPs has been discovered and isolated. Between them, 
DsRed is the representative mother for generating a family of mutants, as shown in Fig. 5. 
Obtained from mutation experiments for improving efficiency of chromophore formation 50, a 
DsRed variant DsRed.T1 was chosen as the starting point for developing dimeric or monomeric 
mutants. Campbell et al successfully interrupted formation of the tetrameric structure through 
inserting Arg with positive charge at the positions central to the interface between subunits to 
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create electrostatic repulsion. With a total of 33 amino acids being substituted, the first 
monomeric RFP, mRFP1, was generated 51. It was then quickly adopted by scientists as a fusion 
tag in multiple applications. However, its incomplete formation of chromophore, unpredictable 
brightness and poor photostability for long-time imaging reduced its reliability. To overcome 
these weaknesses and to produce FPs emitting different fluorescence, a lot of efforts was done to 
improve mRFP1, including exchanging Gln66 and/or Tyr67 on the chromophore with Met, Cys, 
Thr and/or Trp, and substitution of residues surrounding the chromophore. Many high-
performing YFPs and RFPs widely adopted today were developed, as shown in Fig. 6, and they 
are now known as “mFruits”. Specially, mApple is the parent of a RFP variant, K78BoF, directly 
involved in my project, so more details about mApple is provided later.   
 
Fig. 5 Flowchart for the development of FP variants derived from DsRed 42, 52.  
 
DsRed 
 
DsRed.T1 
mRFP1 
dTomato 
tdTomato 
mOrange mStrawberry mTangerine mHoneydew mCherry mPlum 
mApple 
mOrange2 
LSSmOrange 
mBanana 
mBlueberry 
mBlueberry2 
mRaspberry 
mGrape3 
mGrape2 
mGrape1 
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(a)  
(b)  
Fig. 6 Some purified DsRed-derived FP variants shown in visible light (a) and fluorescence 
(b) 52. From left to right, the order of the proteins is as follows: mHoneydew, mBanana, 
mOrange, tdTomato, mTangerine, mStrawberry, mCherry.  
 
        The other classical case for developing a system of FP variants comes from E. quadricolor, 
in which two RFPs eqFP578 and eqFP611 were isolated and mutated into diverse high-efficient 
variants, as shown in Fig. 7. The first monomeric variant from E. quadricolor, TagRFP, was 
derived from eqFP578 through many rounds of random or semi-random mutagenesis, which was 
2.8-folder-brighter than mCherry and considered to be the brightest at that time 34. Then it was 
rationally mutated into TagRFP-T through a substitution of S158T, and is one of the most 
photostable monomeric FPs currently 53. Especially interesting is the fact that TagRFP could 
even be converted into a bright monomeric BFP, mTagBFP, with lmax at 456nm through a 
replacement of Met63 to Leu and mutations on several residues surrounding. It creates a 
completely different chromophore structure to other BFPs, as shown in Fig. 4f 54, 55. Meanwhile, 
another direction for mutating eqFP578 was conducted to screen out variants with long emission 
wavelength. Katushka was selected with lmax at 635nm and further optimization on it resulted in 
several far-red FP variants created, including mNeptune, a far-red FP three-fold brighter than 
mPlum at 650nm 56, 57. Although eqFP611 was discovered first, its variants were successfully 
generated much later than those of eqFP578. The most representative one is a RFP, mRuby, 
which is closely related to my project and is discussed in detail later. 
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Fig. 7 Flowchart for the development of FP variants derived from eqFP578 and eqFP611, 
two RFPs isolated from E. quadricolor 42. 
 
3. Application of FPs or FP variants 
        Ever since Chalfie et al proved that avGFP could be expressed in eukaryotic cells without 
cytotoxicity or losing the green fluorescence 10, FPs were widely applied to monitor the 
activation of promoters or expression of proteins through inserting FP genes after promoter 
regions or fused to the target genes 13. Later, multiple FP-based biosensors were developed for 
experimentally reading out molecular interactions between a FP-labeled protein and an analyte of 
interest which could be a small molecule, a protein or an enzymatic activity 58.  Now FP-based 
biosensing is one of the most important applications of FPs.  
        Depending on the design and purpose of an experiment, one FP or two may be employed. 
Single FP-based biosensors are usually composed of a premature FP and an exogenous or 
E. quadricolor 
eqFP578 eqFP611 
mRuby 
TagRFP Katushka 
TagRFP-T mKate
mKate2
mTagBFP
mNeptune
eqFP670 
eqFP650 
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endogenous protein. When a small molecule or an ion binds to the FP or fused protein, the 
conformation of the chromophore will switch into the active state and fluorescence can be 
detected. Biosensors in this kind have successfully measured concentration of Ca2+, Zn2+, ATP, 
cGMP in vivo 58. Two FPs-based biosensors, commonly known as Förster resonance energy 
transfer (FRET)-based biosensors, are particularly valuable in analyzing enzyme activity and 
protein-protein interactions in vivo. In FRET between two FPs, a nonradioactive energy transfers 
from an excited donor chromophore to an acceptor chromophore in a distance less than 10nm,  
triggering the acceptor emitting fluorescence. When a protease splits the substrate labeled by two 
FPs with different colors on each terminal, fluorescence of the acceptor will be diminished 
because of the increasing distance. Alternatively, interaction between two proteins tagged with 
FPs can be traced through detecting the light emission from the acceptor, which was used to 
study the oligomerization state of members in the G-protein-coupled-receptor superfamily. 
        Actually, research in FP applications was more difficult than originally expected. Despite 
that avGFP shows a lot of strengths in application mentioned before, the weaknesses for it and 
most of other FPs with short-wavelength spectra are obvious. The strong photobleaching and low 
transmission rate in cells strikingly reduced the practicability as biosensors. These become 
motivations for scientists to develop RFP variants in recent years, for long-wavelength red 
fluorescence scatters less in vivo and penetrate tissues better. Also, living cells are less sensitive 
to longer wavelength excitation and the autofluorescence from cells can be reduced under this 
condition. Moreover, the development of RFPs can help to achieve the two-color living-cell 
imaging, which was prevented by the overlapping emission spectra of early variants. Extension 
of the emission range into the red and even the far-red area helps to better distinguish the 
emission peaks between different colors 59.  
        Before RFP was available in the lab, it was CFP-YFP pairs were commonly used in FRET 
experiments, but they were also problematic because of phototoxicity, photobleaching and 
photoconversion 60. Now some GFP-RFP pairs are able to conquer the difficulties 61. For 
example, in 2016, mClover3-mRuby3 pair was used with satisfactory brightness and 
photostability, and successfully employed to improve response in the calcium/calmodulin-
dependent kinase II alpha (CaMKIIα) reporter 62.  
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4. Two RFPs in my research 
4.1 Protein K78BoF 
        Dr. Huiwang Ai’s lab at University of California, Riverside mainly focuses on developing 
novel molecular probes by protein engineering, fluorescence and bioluminescence imaging, and 
synthetic chemistry techniques, to molecularly monitor signal pathways involving redox-active 
molecules, neurotransmitters, and protein post-translational modifications in the real time. The 
research efforts are applied to clarify mechanisms of toxicity of chemicals, cancer development 
and progression, cognition and behavior, and neurological disorders. Recently, they successfully 
developed a number of FP-based biosensors for imaging mitochondrial membrane, detecting 
peroxynitrite or Zn2+ and monitoring thioredoxin redox activity, and so on. Specifically, a GFP-
based biosensor, pnGFP, was generated by introducing an unnatural amino acid, p-
boronophenylalanine (BoF) (Fig. 8), to selectively detect production of peroxynitrite in vivo, a 
redox signaling molecular related to some serious diseases including various cancers and 
Alzheimer’s disease 63. 
   
Fig. 8 Chemical structure of p-boronophenylalanine (BoF).  
 
        Protein K78BoF, provided by the Ai lab in this project, is an RFP-based sensor used to 
sense peroxynitrite and hydrogen peroxide. It was improved from circularly permuted mApple 
by substituting Lys30 with BoF. As an ideal parent protein, mApple was derived from mOrange, 
a variant of wild-type RFP DsRed (Fig. 5), by mutation on the chromophore (T66M) and 
multiple residues on the β-barrel, resulting in red-shifting to 592nm for lmax and showing 
brighter fluorescence than mCherry 53. The experimental results from the Ai lab show that the 
further mutation of mApple by BoF offers K78BoF a biosensing function, but the protein 
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becomes sensitive to the change of pH at the same time. When the pH value is lower than 
approximately 7.5, it loses its red color and visually turns to yellow. Further study by crystal 
structure determination may assist the Ai lab to clarify the possible reason. 
 
4.2 Protein mRuby0.4-3 
        Dr. Jun Chu’s lab at Shenzhen Institutes of Advanced Technology, Chinese Academy of 
Sciences was founded in 2016. His current research interests include developing new single 
RFP-based biosensors for living cell imaging and improving FPET-based biosensors for 
monitoring in vivo activity of kinases.  
        As a novel RFP-based biosensor developed from mRuby3, mRuby0.4-3 was provided a 
gene inserted in a plasmid by the Chu lab.  
        mRuby was derived from eqFP611 through mutation of F102I, insertion of Arg122 and 
Ala194, and the replacement of C-terminal sequence and amino acids that prevented 
chromophore folding correctly 64. Its chromophore can be formed in several hours with unusually 
bright red fluorescence emitted at 605nm, which fills the spectra gap between green/yellow and 
far-red FPs with very high extinction coefficient but low quantum yield. It also shows strong 
resistance to denaturation in the broad range of pH. Because of the advantages it displays, it was 
further engineered to improve brightness, maturation time, and photostability. The second and 
third generation mRuby2 and mRuby3 were developed and successfully applied in GFP-RFP 
FRET experiments 60, 62. Furthermore, mRuby3 is currently one of the brightest monomeric RFP 
tags. As the daughter of mRuby3, mRuby0.4-3 maintains similar strengths, but also shows 
tolerance to a narrow pH range from 6.0 to 7.0 for fluorescence emission. The red fluorescence is 
diminished significantly when pH is lower than 6.0 or higher than 7.0. To explain this 
phenomenon, understanding how the conformation of the protein change at different pH values is 
essential.  
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RESEARCH GOALS 
 
1. Crystal structure determination of K78BoF 
        This project is to identify the effect of p-boronophenylalanine (BoF) substituting for Lys30 
on fluorescence of the protein through analyzing the crystal structure of K78BoF in a weakly 
acidic or neutral environment, which will provide data support to the further development of 
K78BoF on research.  
 
2. Crystal structure determination of mRuby0.4-3 
        Two goals are expected in this project. The first one is to decipher the 3D structure of this 
new red FP variant. The second goal is to describe the effect of pH change on the conformation, 
given that its fluorescence is pH-sensitive.   
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MATERIALS AND METHODS 
 
1. General scheme 
        To obtain a crystal structure of a protein, four steps of operation are usually required, as 
shown in Fig. 9. Firstly, the protein is overexpressed in E. coli cells transformed with the protein-
gene-inserted plasmid. Then the cells are harvested and lysed, followed with nickel-affinity 
column and size exclusion chromatography purifications sequentially. When the protein is pure 
enough for crystallization, preliminary screening of crystallization conditions is conducted to 
narrow down the potential conditions. Depending on the result of the screening, further 
optimization of the selected methods may be necessary to gain crystals with good quality. The 
crystals collected are shot with X-rays, and diffraction patterns are recorded for data analysis and 
solving the 3D structure. 
        Protein K78BoF was prepared by Ai’s lab and sent to Ng’s lab in a purified situation, so it 
was ready for crystallization experiments. Protein mRuby0.4-3 was provided as a gene inserted 
into a plasmid by Chu’s lab, thus my research started from the first step. Expression of protein 
and purity of proteins in each purification step were checked by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). 
 
Fig. 9 General scheme for 3D-structure determination of proteins.  
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2. Techniques applied in protein expression and purification 
2.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
        Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a technique 
used to analyze proteins or peptides based on their weight difference in an electrical field. As an 
anionic detergent, SDS disrupts the secondary, tertiary and quaternary structures of proteins and 
turns them into linear polypeptide chains. Meanwhile, it binds to the chains in a ratio of 
approximately one SDS molecule to two amino acids, making them negatively charged 
proportionally to protein mass. The technique is able to separate proteins with molecular weight 
from 5 to 2,000 kDa. When subjected to an electric field in PAGE, the peptide chains move 
toward the anode at different rates inversely related to their weight. The denatured proteins can 
be then separated and analyzed through dyeing the gel with Coomassie blue.  
        Mini-PROTEIN® TGXTM Gels purchased from Bio-Rad Laboratories, Inc. with acrylamide 
percentage in 8-16% were applied to check the efficiencies of protein expression and purities of 
proteins here. The samples were mixed with loading buffer and loaded into the wells of the gel. 
The gel was submerged in tris-glycine buffer and run in an electrical field under no more than 
200V. Then the gel was rinsed by DI water three times with 15 minutes each time, and stained in 
Coomassie blue under room temperature for about one hour. After rinsing it by DI water once, 
the gel was ready for analysis. 
 
2.2 Nickel-column purification 
        Because the six histidine residues tagged onto the amino acid sequence of mRuby0.4-3 
show high affinity to immobilized nickel ions (Ni2+), columns filled with Ni2+-immobilized 
resin can selectively retain the tagged proteins while other proteins or contaminants are washed 
away with buffer. Then the proteins can be gently eluted through competition by high 
concentration of imidazole 64.  HisTrapTM FF crude column prepacked with 1mL of precharged 
Ni Sepharose™ 6 Fast Flow, produced by GE Healthcare, was utilized in the purification step of 
mRuby0.4-3. Solutions used are listed in Table 2. 
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        After washing the column with 6mL of DI water, I equilibrated it with 6mL of washing 
buffer. Then I loaded the sample into the column and collected the solution eluted. The column 
was washed by 15mL of washing buffer for removing the contaminants not binding to it, while 
the eluted liquid was collected as well. After that, I injected 6mL of elution buffer into the 
column and collected the eluate into different tubes for every 1mL. The column was regenerated 
through being rinsed by a series of solutions with a syringe, in an order as follows: 10mL of 
stripping buffer, 6mL of 8M urea, 5mL of binding buffer, 5mL of DI water, 30mL of cleaning 
solution, 10mL of binding buffer, 10mL of DI water, 1mL of charging solution, 5mL of DI 
water, 5mL of binding buffer.  
 
Table 2 Components of solutions applied in nickel-column purification. 
Solution Component (with concentration and pH) 
Striping buffer 20mM Sodium Phosphate, pH 7.4 * 
0.5M Sodium Chloride 
50mM EDTA 
Binding buffer 20mM Sodium Phosphate, pH 7.4 * 
0.5M Sodium Chloride 
Cleaning solution 1M NaOH 
1.5M NaCl 
Charging solution 0.1M NiSO4 
Washing buffer 20mM Imidazole 
20mM Tris, pH 8.0 
Elution buffer 200mM Imidazole 
20mM Tris, pH 8.0 
* To prepare 20mM Sodium Phosphate, pH 7.4, Henderson-Hasselbach equation, pH = pKa + 
log ([Na2HPO4]/[NaH2PO4]), with pKa of 6.9 was employed to calculate the mass of Na2HPO4 
and NaH2PO4. 
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2.3 Size exclusion chromatography 
        Size exclusion chromatography (SEC) is a method for separating macromolecules such as 
proteins in a solution by molecule size. Usually it is performed with a column filled with porous 
polymer beads. When solutions travel down the column, smaller molecules are trapped in the 
pores while the larger molecules pass between the beads and elute faster. Here mRuby0.4-3 
solution was purified through prepacked SuperdexTM 75 10/300 GL column using an ÄKTA 
protein purification system from GE Healthcare Life Sciences. To prepare the column before 
purification, it was washed with sterilized DI water for 2h and then equilibrated by elution buffer 
(20Mm Tris, 100Mm NaCl, pH 7.5) for about 1h at a flow speed of 0.6mL/min. After sample 
solution was loaded into the column, elution buffer was applied as mobile phase to separate 
proteins at a flow speed of 5.0mL/min. The eluate was collected into different test tubes for 
every 2 minutes controlled by a fraction collector. When purification was completed, the column 
was washed by sterilized DI water for 2h. 
 
3. Protein crystallization 
3.1 Preliminary crystallization method screening  
        MCSG (Midwest Center for Structural Genomics) crystallization suites purchased from 
Anatrace were utilized for preliminary crystallization method screening. There are four screen 
suites available in Ng’s lab with 96 different crystallization conditions in each one, which are 
MCSG-1, MCSG-2, MCSG-3 and MCSG-4. Each condition contains salt, buffer and/or 
precipitant. Conditions 1-288 in MCSG-1, MCSG-2, MCSG-3 are arranged in a decreasing order 
of crystal productivity according to results of trials of more than 40,000 diverse proteins, while 
conditions in MCSG-4 are rationally selected for proteins requiring additional screening. 
        The Crystal Gryphon (Fig. 10) produced by Art Robbins Instruments, LLC was employed 
to distribute protein solutions and crystallization reagents in MCSG suites on the wells of Intelli-
Plate 96-3 LVR crystallization plates (Fig. 11, purchased from Hampton Research) in three 
different volume ratios between two solutions as shown on Table 3.  
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Fig. 10 Picture of Crystal Gryphon. 
 
A.  B.    
Fig. 11 Intelli-Plate 96-3 LVR crystallization plate (A) and well arrangement for each 
condition (B).  
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Table 3. Volume of protein solution and crystallization reagent placed on each well of 
Intelli-Plate 96-3 LVR crystallization plate. 
Well Vprotein (µL) Vreagent (µL) 
1 0.375 0.125 
2 0.250 0.250 
3 0.125 0.375 
 
3.2 Microseeding experiments 
        In a crystallization experiment, addition of a crystallization reagent to the protein solution 
can increase the relative supersaturation of the protein which favors nuclei formation and then 
crystal growth. According to the difficulty of crystal nucleation and growth, supersaturation can 
be divided into three stages, metastable zone, labile zone and precipitation zone sequentially 
(Fig. 12). In the metastable zone, nuclei cannot form but crystal growth from seeds can occur, 
while spontaneous nucleation and crystallization can happen in the labile zone, and protein will 
precipitate in the precipitation zone. This means that spontaneous nucleation requires higher 
degrees of supersaturation of the protein solution than crystal growth, to make sure the nuclei can 
reach a critical size to grow into a crystal rather than redissolve. However, as a technique widely 
employed to bypass spontaneous nucleation, seeding can assist to obtain crystals with bigger size 
and better quality. There are mainly two ways to conduct a microseeding experiment, streak 
seeding and solution microseeding 66. Because of its easier operation and controllability in an 
experiment, I chose to perform solution microseeding.  
        Solution microseeding experiment requires preparation of a seed stock solution via using 
the Teflon Seed Bead kit (Hampton Research). Protein crystals were picked under microscope 
and transferred into an iced 1.5mL-centrifuge tube with a bead (Fig. 13). Then the related 
crystallization reagent was added to the tube to make the total volume to be approximately 50µL. 
The tube was vortexed for three minutes with a pause on ice for every 30 seconds. The seed 
stock was then ready and stored at -80℃. Different dilutions of the stock were also prepared 
based on the experiments and stored at -80℃. 
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        In a microseeding experiment, protein solution, crystallization reagent and seed solution 
were mixed in fixed volume ratios which depended on the crystallization condition and the 
experiment design.   
 
 
Fig. 12 Seeding and phase diagram 66. 
 
 
Fig. 13 Seed bead (pink ball) and operation for preparing seed stock solution. 
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3.3 Additive screening experiment 
        The Additive Screen HT TM kit produced by Hampton Research contains 96 wells of 
different solutions, including multivalent cations, salts, amino acid, dissociating agents, linkers, 
polyamines, chaotropes, co-factors, reducing agents, polymers, chelating agent, carbohydrates, 
polyols, non-detergents, amphiphiles, detergents, osmolyte, organic (non-volatile) or organic 
(volatile) reagents. By adding to conditions in the MCSG suites, it will adjust the environment of 
protein crystallization including altering pH of crystallization reagents, vapor rate of water, etc. 
The results may facilitate or diminish the crystallization.  
        Additive screening experiment was conducted using the Crystal Gryphon to mix the 
solutions with protein solutions and crystallization reagents in fixed volume ratios.    
 
4. Protein crystal structure determination 
        Crystals were picked from wells using cryoloops under microscope, rinsed by cryo-
protectant and stored in liquid nitrogen, then sent to the Advanced Light Source at Lawrence 
Berkeley Lab at University of California, Berkeley for collection of single-crystal 
monochromatic diffraction patterns through using the SIBYLS beamline there. X-ray Detector 
Software (XDS) 66 was employed to convert the patterns into structure factors and then Phaser 67 
was used to perform molecular replacement. The structure model was refined and rebuilt 
manually by Coot 0.8.9-pre EL 68 and computationally by Refmac5 in CCP4 69. Crystal 
structures of K78BoF and mRuby0.4-3 were performed with The PyMOL Molecular Graphics 
System, Version 1.8 Schrödinger, LLC. 
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RESULTS 
 
1. Crystallization of K78BoF 
1.1 Purity of K78BoF 
       Because the purity of a protein plays an important role in crystal growth and quality, a SDS-
PAGE gel was run to check the purity of K78BoF when it arrived. The gel result in Fig. 14A 
showed that K78BoF was the majority of the protein solution, although small amounts of other 
proteins were found. The solution was pure enough for protein crystallization.  
 
A          B  
Fig. 14 SDS-PAGE gel result of K78BoF (A) and protein solution in 20mg/mL (B). On A, 
lane 1, 2 and 3 were for prestained protein ladder, protein S62BoF, and K78BoF respectively.  
S62BoF was another red FP protein sent with K78BoF planning for crystal structure 
determination. However, the purity of S62BoF was not good enough for further study, so it was 
not mentioned in the project. 
 
 
1       2   3 
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1.2 Crystallization of K78BoF 
1.2.1 Crystallizing method screening 
        To find suitable conditions for crystallizing K78BoF, preliminary screening was conducted 
with MCSG-1 and -2 suites in 20mg/mL of K78BoF at 13℃ for two weeks. Three potential 
conditions, MCSG-1: G10, MCSG-1: G11, and MCSG-2: D12, were identified as seen in Fig. 15 
and Table 4. In MCSG-1: G10 condition, spherulites were formed with identical color of the 
protein solution. Spherulites are transparent, droplet-like solids showing dark and light parts 
under the polarizer, whose growth is a good starting point for condition optimization 66. In both 
MCSG-1: G11 and MCSG-2: D12 conditions, yellowish crystals were formed. Since K78BoF 
will change color from red to yellow in an acidic environment, the crystals formed should be 
K78BoF instead of salt. Although both are yellow, needle-type crystals, the ones in the MCSG-1: 
G11 condition were apparently thicker and clearer in shape, favoring X-ray diffraction 
experiments. Therefore, I chose MCSG-1: G10 and MCSG-1: G11 conditions for the following 
optimization experiments. 
 
Table 4 Chemical components for potential crystallization conditions of K78BoF. 
Condition Salt Buffer Precipitant 
Vprotein: 
Vreagent 
Crystal 
Type*  
MCSG-1: G10 0.1M magnesium 
formate 
 15%(w/v) PEG 3350 1:1 Spherulites 
MCSG-1: G11  0.1M Na2HPO4: 
Citric acid pH 4.2 
40%(v/v) PEG 300 1:3 1D 
MCSG-2: D12 0.2M ammonium 
sulfate 
 20%(w/v) PEG 3350 1:1 1D 
* According to the shape of crystals, they usually can be divided into three different types, 1D 
crystals for spine/needle-like shape, 2D crystals for thin plate shape, 3D crystals for chunk shape.  
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A         B  
C    D  
             E  
Fig. 15 Potential conditions for crystallizing K78BoF at 20mg/mL. (A) MCSG-1: G10 
condition. (B) Crystal grown in MCSG-2. (C) Crystal grown in MCSG-1. (D) Crystal in MCSG-
1: G11 condition shows significant birefringence under polarizer.  (E) Crystal grown in MCSG-1 
in an amplified view. 
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1.2.2 Optimization of MCSG-1: G11 condition   
        A number of parameters need to be considered to optimize the crystallization method, 
including protein concentration, pH of crystallization reagent, concentration of salt, buffer and 
precipitant in the reagent, and volume ratio of protein solution to the reagent. Temperature 
affects crystal growth as well 66.  
        In the first run, the effects of K78BoF concentration on growing crystals was explored by 
increasing the initial protein concentration from 20mg/mL to 55mg/mL. The crystals appeared in 
a week after mixing protein solution and crystallization reagent, then it took another two weeks 
to grow larger. Compared to the crystals from 20mg/mL of K78BoF (Fig. 15E), they showed 
more intensive color, larger size, and thicker shape, indicating that higher concentration favors 
the generation of the crystals. However, crystals shown on Fig. 15E and Fig. 16C grew in 
clusters with overlap of other pieces, which might create an issue in X-ray diffraction since it 
requires a single piece of crystal. Thus, further optimization was needed.  
        To speed up crystal growing and improve crystal quality, a microseeding method was 
applied to the following optimization experiments with seed stock prepared from crystals in Fig. 
16.  
        In microseeding experiment I, the effect of protein concentration and seed concentration on 
crystal growth was studied with experimental design and result shown on Table 5. All nine trials 
were found growing needle-shape crystals. The amount of crystals was increased with increasing 
protein concentration, while the size and the brightness of the color were increased with 
decreasing seed concentration.  
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A    B  
C  
Fig. 16 Crystal grown in MCSG-1: G11 condition with initial protein concentration at 
55mg/mL. The crystallization happened at 13℃. (A) The crystal was observed without 
polarizer. (B) The crystal was observed under polarizer. (C) Crystal observed in an amplified 
view. 
 
Given the brighter color and thicker shape, a number of crystals grown in the adjusted condition 
b3, c2 and c3 on Table 5 were picked for X-ray diffraction analysis. The diffraction of the crystal 
from b3 was too weak to be analyzed. The one from c3 was measured to about 2.6Å, which 
should be good enough to interpret the backbone and most sidechains of K78BoF. Yet the 
diffraction data could not be collected because several diffraction patterns overlapped with each 
other, meaning that more than one crystal were shot by X-ray in the same time. Luckily, a single 
crystal from c2 provided a very clean diffraction pattern with 2.13Å resolution. Its data was 
collected and ready for 3D-structure determination. However, the MCSG-1: G11 condition 
crystallized the protein in a relative low pH environment, which was still far from what we 
expected, meaning more optimization experiments were needed. 
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Table 5 Microseeding experiment I of K78BoF in MCSG-1: G11 condition with different 
protein concentrations and seed solutions.  
* Seed 
Stock 
Dilution  
Protein Concentration (mg/mL) ** 
11 22 33 
1:1 
   
1:10 
   
1:100 
   
* Seed stock solution was ten-fold diluted by MCSG-1: G11 reagent.   
** 55mg/mL of protein solution was diluted to 11mg/mL, 22mg/mL and 33mg/mL by buffer 
(20mM Tris, pH 8.0).  
 
 
a1 a2 a3 
b1 b2 b3 
c1 c2 c3 
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A    B  
Fig. 17 Crystals grown in additive screen combining with microseeding for 20mg/mL of 
K78BoF in MCSG-1: G11 condition. The additive screen was conducted in 13℃ with a 
volume ratio of solutions as follows: (protein solution): (crystallization reagent): (additive screen 
reagent): (hundred-fold diluted seed stock) = 5: 4: 1: 1. (A) Additive screen-A2 condition: 0.1M 
Cadmium chloride hydrate. (B) Additive screen-B7 condition: 0.5M sodium fluoride.    
 
        An additive screen combined with microseeding was conducted to improve the possibility 
of crystal growth. After incubating the plate for 6 days, only two conditions were found to grow 
yellowish crystals (Fig. 17). These conditions showed thinner needle shapes than the previous 
crystals, indicating the adjustments created by reagents in additive screen could not facilitate 
K78BoF to form crystals with higher quality. 
        Given the unexpected results from the additive screen experiment, focus on optimization of 
MCSG-1: G11 condition itself seemed to be a better direction to obtain higher-resolution 
crystals. Thus, more microseeding experiments based on MCSG-1: G11 condition were 
developed.  
        Microseeding experiment II was designed to explore the effects of pH value of the buffer 
and types of precipitants on crystal growth for 10mg/mL and 20mg/mL of K78BoF at 4℃ (Table 
6). Multiple aspects were considered when I designed it. As the goal of this project is to solve 
K78BoF structure at a pH close to 7.0, increasing the pH value became necessary. Being a 
commonly used precipitant, PEG is able to induce protein–protein attractive interactions to form 
precipitates including crystals. Its molecular weight and concentration also influence the 
	 33	
crystallization of proteins 70. Thus, PEGs with different molecular weight and concentration were 
introduced to the experiment. Also, the temperature can affect the vapor rate of water molecules, 
which will further affect the growing speed of crystals. Lowering the temperature can help to 
form crystals with slower rate but better quality.  
        After incubating for approximately two weeks, crystals were generated in the conditions 
labelled on Table 6. Generally, low protein concentration and pH value favored crystal growth, 
but crystals could be grown in high pH, implying the possibility of achieving that goal. However, 
the crystals were grown in clusters with needle-shapes (Fig. 18A) or in lumps (Fig. 18B), which 
created problems in the X-ray diffraction experiments. Although several plate-shape crystals 
were found (Fig. C), they were too thin for analysis by X-ray diffraction.  
        Many crystals were picked from different conditions for X-ray shooting, but none of them 
could provide clear enough diffraction pattern for 3D-structure determination. The patterns were 
either cracked or smeared, meaning the crystals overlapped with each other or the crystal 
structure was partially disordered. The growth condition or the cryo-protectant was not suitable 
to the protein. 
 
Table 6 24-well plate arrangement for microseeding experiment II with 0.1M Na2HPO4 and 
1000-fold diluted seed stock at 4℃.  
pH 35%(v/v) PEG 400 35%(v/v) PEG 500 30%(w/v) PEG 1000 20%(w/v) PEG 1000 
4.2 A1*△ A2*△ A3*△ A4* 
5.0 B1*△ B2*△ B3*△ B4 
6.0 C1*△ C2* C3*△ C4 
8.0 D1* D2 D3 D4 
* Crystals were grown in the well under the condition with 10mg/mL of K78BoF. 
△	Crystals were grown in the well under the condition with 20mg/mL of K78BoF.	
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A    B    C  
Fig. 18 Some representative crystals grown in microseeding experiment II with 20mg/mL 
of K78BoF. (A) Needle-like crystals grown under A4 condition. (B) Crystals grown in a lump 
under C2 condition. (C) Plate-shape crystals grown under C4 condition. 
 
        Despite salt concentration being a small factor compared to pH value of the buffer or 
concentration of precipitants in crystal growth, it was worthy of a trial since no ideal crystals 
were obtained in the previous experiments. Microseeding experiment III was designed, as shown 
on Table 7, which was similar to microseeding experiment II, except for the addition of 0.05M 
Na2HPO4 rather than 0.1M. Unfortunately, no significant improvement in crystal quality or X-
ray diffraction results was gained.   
 
Table 7 24-well plate arrangement for microseeding experiment III with 0.05M Na2HPO4 
and 1000-fold diluted seed stock at 4℃.  
pH 4.2 5.0 6.0 7.0 8.0 
35%(v/v) PEG 400 A1*△ A2 A3* A4*△ A5*△ 
35%(v/v) PEG 500 B1*△ B2* B3*△ B4 B5 
30%(w/v) PEG 1000 C1*△ C2*△ C3*△ C4 C5 
20%(w/v) PEG 1000 D1* D2* D3 D4 D5 
* Crystals were grown in the well under the condition with 10mg/mL of K78BoF. 
△	Crystals were grown in the well under the condition with 20mg/mL of K78BoF.	
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        After trying to change several parameters in the condition, the best crystallization condition 
seemed to be the original one, MCSG-1: G11. The crystal grown in the c2 condition of 
microseeding experiment I offered a clear diffraction pattern with a high resolution. Its crystal 
structure was analyzed below. 
 
1.2.3 Optimization of MCSG-1: G10 condition   
        Increasing protein concentration, changing the ratio of protein solution to crystallization 
reagent, and microseeding experiments were executed when I tried to optimize MCSG-1: G10 
condition for crystallizing K78BoF. Unfortunately, no crystals were found on the plates. 
Considering the limited amount of the protein we had, further investigation in this part was 
stopped.    
 
1.3 Analysis on crystal structure of K78BoF 
        After screening dozens of crystal samples at the X-ray beamline, only one provided clear 
enough single-crystal monochromatic diffraction patterns with resolution to 2.13Å for 3D-
structure determination at pH 6. The monomeric crystal structure (Fig. 19) coincides with 
characteristics of GFP-like proteins. Eleven connected β-strands construct a cylinder surrounding 
the chromophore with an α-helix running through the axis of the cylinder and linking them 
together. K78BoF crystallized in monoclinic space group C121 with unit cell dimensions of a = 
84.2Å, b = 34.6Å, c = 88.8Å, α = γ = 90º, β = 110.9º (Table 8).  
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Fig. 19 An overview of crystal structure of protein K78BoF at pH 6. The chromophore is 
shown in red stick representation while BoF is shown in blue stick representation with carbon 
atoms in green color, oxygen in red and nitrogen in blue.  
Table 8 Crystallographic data for crystal structure of K78BoF. 
Space group C121 
Cell dimensions: a (Å) 84.203         
Cell dimensions: b (Å) 34.567 
Cell dimensions: c (Å) 88.815 
Resolution (Å) 83.0-2.13 
Completeness (%) 94.89 
R/Rfree 0.1894/0.2608 
Rmsd bond lengths (Å) 0.0352 
Rmsd bond angles (º) 1.9395 
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        Formed by Met175-Tyr176-Gly177, the chromophore of K78BoF fits well in the electron 
density map at a sigma level of 1.0 (Fig. 20A) and exists in the cis state at pH 6 without any 
electron density observed in the position for the trans state. Two water molecules were located 
near the chromophore, near Gln173, Gln218, and Ser220 with interatomic distances less than 
3.5Å to them (Fig. 21). Hydrogen bonds on the terminal carbonyl oxygen of the conjugated π 
system are believed to stabilize the excited state and decrease the HOMO-LUMO energy 
difference, resulting in red-shift of the absorbance 56. The amino group on the side chain of 
Arg204 is also close to the chromophore with an interatomic distance of 2.7Å to another 
carbonyl oxygen, implying a possible hydrogen bond and a potential contribution to the red 
fluorescence emitted.  
 
A     B  
Fig. 20 Structures of K78BoF chromophore (A) and BoF (B) in electron density maps. The 
chromophore is shown in sticks in an electron density map at 1.0 sigma level while BoF is shown 
in sticks in a map at 0.5 sigma level. 
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Fig. 21 Possible hydrogen bonds (shown in dotted lines) connecting to the chromophore of 
K78BoF. Bond lengths were measured by PyMOL with units in Å.  
 
        To analyze the effect of the replacement of BoF to Lys30 on the conformation of the 
protein, the crystal structure of R-GECO1 (PDB 4I2Y) was obtained from Protein Data Bank to 
compare with K78BoF 72. R-GECO1 is a tetrameric mApple variant with a difference of four 
residues in the β-barrel 72. As can be seen in Fig. 22A, K78BoF is well superimposed upon the 
backbone of one subunit of R-GECO1, indicating that no significant structural alternation 
happens because of the substitutions. The five-member rings and the terminal carbonyl groups of 
chromophores perfectly overlap with each other, yet the phenolic moiety of K78BoF deviates by 
7.4º as calculated by PyMOL (Fig. 22B). Moreover, the mutation breaks the hydrogen bonds of 
the hydroxyl oxygen on the phenolic moiety. In the crystal structure of R-GECO1, a hydrogen 
bond exists between Lys78 and the chromophore when another hydrogen bond between Ser62 
and Lys78 stabilizes it (Fig. 23B). However, after the Lys is replaced by BoF, the interatomic 
distances are extended to 4.2Å between BoF and the chromophore and 11.5Å between BoF and 
R204 
Q173 
Q218 
S220 
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Ser14 (Fig. 23A), both of which are too far to build hydrogen bonds. It could be a reason for the 
angle deviation of the phenolic moiety of K78BoF.  
        An important point to mention is that the electron density for the two hydroxyl groups can 
hardly be found bonding to the boron atom on BoF, even at a sigma level of 0.5 (Fig. 20B). 
Since the in vivo stability of BoF has been proven for years 74, this situation is probably caused 
by other reasons, instead of a chemical change.  
 
A    B  
Fig. 22 Alignment of K78BoF crystal structure at pH 6 with R-GECO1. (A) The structure of 
K78BoF is in green and R-GECO1 is cyan. (B) The chromophore structure of K78BoF is in red 
color and R-GECO1 is cyan. 
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A  B  
Fig. 23 Distance among chromophores, serine and lysine residues or BoF in K78BoF (A) 
and R-GECO1 (B) crystal structures 71. 
 
2. Crystallization of mRuby0.4-3 
2.1 Expression and purification of mRuby0.4-3 
        The plasmid bearing the mRuby0.4-3 gene was transformed into E. Cloni (Lucigen) cells 
through heat shocking at 42℃ for 45 seconds after cooling on ice for 30 minutes. The cells were 
then cultured in TB with ampicillin at 37℃ overnight, followed by decreasing temperature to 
18℃ overnight to overexpress the protein. The cells were harvested and washed by lysis buffer 
(50mM Tris, 25mM NaCl, 1mM PMSF, pH 7.5), then lysed by sonication. After centrifuging 
down the cell fragments, the supernatant was collected via nickel-column purification, followed 
by size exclusion chromatography (Fig. 24A). As can be seen on the gel (Fig. 24B), fractions A9, 
A10, A11, A12, and B12 contained mRuby0.4-3. Because there was significant amounts of 
contaminants in A9, I excluded A9 when combining the fractions to avoid introducing 
contaminants into the purified protein. Purity of mRuby0.4-3 was analyzed through running a 
SDS-PAGE gel (Fig. 25). After two-step purification, most of the other proteins were removed. 
Protein concentration was measured to be about 25.5mg/mL in Nanodrop at 280nm.    
S14 
BoF 
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A  
 
 B  
Fig. 24 Size exclusion chromatography of mRuby0.4-3. (A) The protein separation was traced 
by UV detector. (B) A SDS-PAGE gel was run for fractions containing proteins. On the gel, 
“Elu” means protein eluent after nickel-column purification. 
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A    B    C  
Fig. 25 Purity of mRuby0.4-3 checked by SDS-PAGE gel (A, under visible light; B, under 
blue light) and the purified protein solution (C). On (A), lane 1 was for prestained protein 
ladder, lane 2 and 3 for cell pellet and supernatant respectively after lysis, lane 4 for protein 
solution after nickel-column purification, lane 5 for protein solution after size exclusion. 
 
2.2 Crystallization 
2.2.1 Crystallizing method screening 
        To quickly identify suitable conditions for crystallizing protein mRuby0.4-3, all four MCSG 
suites were applied. After two weeks of incubation, 10 conditions were found generating crystals 
in MCSG-1 suite and 4 in MCSG-2 suite. Also, a condition was found growing crystals in 
MCSG-3 suite after almost four weeks of incubation. Information for these 15 conditions and 
crystal types grown in them are listed in Table 9.  
 
 
1    2   3    4   5   
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Table 9 Conditions able to grow crystals for mRuby0.4-3.  
Condition Salt Buffer Precipitant 
Vprotein: 
Vreagent 
Crystal 
Type*  
MCSG-1: 
A2 
 0.1M CHES: NaOH pH 
9.5 
30%(w/v) PEG 3000 3:1 3D 
MCSG-1: 
C2 
0.2M Lithium 
Sulfate 
0.1M Bis-Tris: HCl pH 
5.5 
25%(w/v) PEG 3350 3:1 1D 
MCSG-1: 
H3 
0.2M Lithium 
Acetate 
 20%(w/v) PEG 3350 1:1 3D 
MCSG-1: 
E4 
0.2M Lithium 
Sulfate 
0.1M Tris: HCl pH 8.5 25%(w/v) PEG 3350 1:1 3D(s**) 
MCSG-1: 
F5 
0.2M Sodium 
Acetate 
 20%(w/v) PEG 3350 1:1 3D 
MCSG-1: 
G7 
 0.1M Tris: HCl pH 8.5 25%(w/v) PEG 3350 1:1 3D 
MCSG-1: 
D8 
0.1M Sodium 
Chloride 
0.1M Bis-Tris: HCl pH 
6.5 
1.5M Ammonium 
Sulfate 
1:3 1D(s) 
MCSG-1: 
D9 
0.2M Sodium 
Chloride 
0.1M Tris: HCl pH 8.5 25%(w/v) PEG 3350 1:1 3D(s) 
MCSG-1: 
C11 
0.2M Calcium 
Acetate 
0.1M Tris: HCl pH 7.0 20%(w/v) PEG 3000 1:1 3D 
MCSG-1: 
E11 
  1.0M NaH2PO4/ 
K2HPO4 pH 8.2 
1:1 2D, 3D 
MCSG-2: 
E3 
 0.1M Bis-Tris Propane: 
NaOH pH 7.0 
1.5M Lithium 
Sulfate 
1:3 2D 
MCSG-2: 
B4 
  1.8M NaH2PO4/ 
K2HPO4 pH 8.2 
3:1 1D(s) 
MCSG-2: 
C7 
 0.1M Tris: HCl pH 8.5 1.5M Ammonium 
Phosphate Dibasic 
3:1 3D 
MCSG-2: 
F7 
0.15M DL-Malic 
Acid pH 7.0 
 20%(w/v) PEG 3350 1:3 3D(s) 
MCSG-3: 
D3 
0.2M Lithium 
Sulfate 
0.1M Tris: HCl pH 7.0 2.0M Ammonium 
Sulfate 
1:1 3D 
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* According to the shape of crystals, they usually can be divided into three different types, 1D 
crystals for spine/needle-like shape, 2D crystals for thin plate shape, 3D crystals for chunk shape.  
** The crystals are too small for X-ray diffraction. 
 
Table 10 X-ray diffraction results for selected 3D crystals of mRuby0.4-3.  
Crystals  X-ray diffraction Results with growth conditions 
 
MCSG-1: A2 
1st: Two crystals were prepared but one was lost 
during cryostorage and the other one gave poor 
diffraction resolution to 7Å.  
2nd: Several crystals were analyzed and one of 
them showed good resolution at 2.83Å with 
clean diffraction pattern. 
 
MCSG-1: F5 
1st: One piece of crystals was analyzed but no 
data was obtained because the diffraction was 
highly smeared. 
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Table 10 (Continued) X-ray diffraction results for selected 3D crystals of mRuby0.4-3.  
Crystals  X-ray diffraction Results with growth conditions 
 
MCSG-1: G7 
1st: Poor resolution of a piece of crystal at 12Å 
was observed from X-ray diffraction.  
 
MCSG-1: C11 
1st: Two pieces of crystals were picked for X-ray 
diffraction. One was lost during cryostorage. 
The other one was successfully tested with a 
resolution at 3.0Å but images were smeared. 
2nd: Five crystals were tested, but all of them 
showed smeared diffraction.  
 
MCSG-1: E11 
1st: Poor resolution at 8Å with smeared 
diffraction with a piece of crystal in this 
condition.  
2nd: Three crystals were tested. One of them 
displayed a clean diffraction pattern with 2.6Å 
resolution. The other two also had good 
resolution, but the crystals were cracked. 
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Table 10 (Continued) X-ray diffraction results for selected 3D crystals of mRuby0.4-3.  
Crystals  X-ray diffraction Results with growth conditions 
 
MCSG-2: C7 
1st: Same as the one in condition MCSG-1: E11, 
the crystal displayed poor resolution at 8Å with 
smeared data.  
 
MCSG-3: D3  
2nd: Four crystals were sent for analysis, but all 
of them had diffraction that were highly 
smeared. 
 
        Usually, 3D crystals with clear edges give better resolution and diffraction patterns in X-ray 
analysis. Crystals grown in conditions MCSG-1: A2, F5, G7, C11, E11, MCSG-2: C7, and 
MCSG-3: D3 were prepared with cryo-protectant LVCO and sent for the first X-ray shooting. 
The pictures of the crystals and the diffraction results were described on Table 10. The 
diffraction for most of crystals from different conditions were smeared, demonstrating that 
LVCO may be not a suitable cryo-protectant for them.  
        Given the many shapes and numbers of the crystals, I selected the ones from MCSG-1: A2, 
MCSG-1: C11, MCSG-1: E11, and MCSG-3: D3 for the second X-ray shooting. Instead of 
LVCO, they were prepared with cryo-protectants made of crystallization reagents with 10% 
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ethylene glycol (for MCSG-1: A2 and MCSG-1: C11) or 25% glycerol (for MCSG-1: E11 and 
MCSG-3: D3). The results were also displayed in Table 10. Crystals from MCSG-1: A2 and 
MCSG-1: E11 with clean diffraction patterns and high resolution were processed for the 
structure model building steps. However, both of these two crystals were produced in a basic 
environment. Since the goal of this project was to investigate the change of the protein 
conformation with the pH value, crystals grown in acidic and neutral conditions are still required.  
 
2.2.2 Optimization of crystallizing method  
        In this part, I focused on optimizing the crystallization condition MCSG-1: A2, MCSG-1: 
C2, MCSG-1: C11, MCSG-1: E11, and MCSG-3: D3 though changing precipitant concentration 
and/or protein concentration, and using the microseeding method.  
        Although crystals from MCSG-1: A2 provided acceptable diffraction to solve the 3D 
structure, further optimization of crystallization method was still conducted to look for crystals 
with higher resolution diffraction. Because our lab does not have CHES, the buffer contained in 
the condition, I could not prepare the crystallization reagent. Yet I still tried to increase the 
protein concentration (Table 11) and the proportion of the protein in the volume ratio, and added 
seed solution into the system (Table 12). However, better crystals were not found by X-ray 
shooting.  
        MCSG-1: C2 was the most acidic condition found being able to grow crystals, even though 
they were needle-like (Fig. 26). Optimization of this condition might assist in obtaining a protein 
structure in an acidic environment. Results from the experiments (Table 12 and 13) showed that 
microseeding favored the crystals growing in lower protein or precipitant concentration, but the 
crystals still grew as needles too thin for X-ray diffraction.  
        MCSG-1: C11 could provide a condition with pH at 7.0 for crystal growth, so it was worth 
doing more work on it, but good results were not obtained from X-ray diffraction, even for 
crystals grown with good shape (Table 11).  
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Table 11 Design of optimization experiment I for condition MCSG-1: C2, MCSG-1: C11, 
MCSG-1: E11 and MCSG-3: D3. 
Condition△ Protein concentration (mg/mL) 
13 26 13 26 
MCSG-1: A2* 30%(w/v) 
PEG3000 C 
30%(w/v) 
PEG3000 C 
__ __ 
MCSG-1: C2*  25%(w/v) 
PEG3350 
25%(w/v) 
PEG3350 
20%(w/v) 
PEG3350 
20%(w/v) 
PEG3350 
MCSG-1: C11** 20%(w/v) 
PEG3350 C 
20%(w/v) 
PEG3350 C 
15%(w/v) 
PEG3350 
15%(w/v) 
PEG3350 
MCSG-1: E11** 1.0M NaH2PO4/ 
K2HPO4 pH 8.2 C 
1.0M NaH2PO4/ 
K2HPO4 pH 8.2 C 
0.75M NaH2PO4/ 
K2HPO4 pH 8.2 
0.75M NaH2PO4/ 
K2HPO4 pH 8.2 
MCSG-3: D3** 2.0M Ammonium 
Sulfate 
2.0M Ammonium 
Sulfate 
1.5M Ammonium 
Sulfate 
1.5M Ammonium 
Sulfate 
△ For each condition, only concentration of precipitant was altered, salt and buffer was same to 
the original. 
* Vprotein: Vreagent = 3:1. 
** Vprotein: Vreagent = 1:1. 
C Crystals were grown in this condition. 
 
 
Fig. 26 Needle-like crystals grown in condition MCSG-1: C2.  
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Table 12 Microseeding experiment for condition MCSG-1: A2, MCSG-1: C2, MCSG-1: 
E11 and MCSG-3: D3. 
Condition△ 
MCSG-1: A2 MCSG-1: C2* MCSG-1: E11** MCSG-3: D3** 
Vprotein: Vreagent: Vseed = 
6:1:1 C 
25%(w/v) PEG3350 C 1.0M NaH2PO4/ 
K2HPO4 pH 8.2 C 
2.0M Ammonium 
Sulfate 
Vprotein: Vreagent: Vseed = 
3:2:1 
20%(w/v) PEG3350 C 0.75M NaH2PO4/ 
K2HPO4 pH 8.2 
2.0M Ammonium 
Sulfate 
△ For each condition except MCSG-1: A2, only concentration of precipitant was altered, salt and 
buffer was same to the original.  
* Vprotein: Vreagent: Vseed = 6:1:1. 
** Vprotein: Vreagent: Vseed = 3:2:1. 
C Crystals were grown in this condition. 
 
Table 13 Design of optimization experiment II combining with microseeding method* for 
condition MCSG-1: C2. 
MCSG-1: C2△ 
Protein concentration (mg/mL) 
6.5 13 
15%(w/v) PEG3350 A1 A2 
20%(w/v) PEG3350 B1    B2 C 
25%(w/v) PEG3350   C1 C    C2 C 
△ For each condition, only concentration of precipitant was altered, salt and buffer was same to 
the original.  
* Vprotein: Vreagent: Vseed = 6:1:1.  
C Crystals were grown in this condition. 
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   Similar to MCSG-1: A2, although a clean diffraction pattern was received, optimization of 
MCSG-1: E11 was still performed to obtain crystals that diffract to higher resolution. According 
to the results on Table 11 and 12, crystals could not be generated in lower precipitant 
concentrations, even though the microseeding method was applied. Some crystals were selected 
and ready for analysis by X-ray. 
        The brownish color of the crystals grown in MCSG-3: D3 (Table 4) deviated from the 
original color of the protein, which was interesting to note for further investigation. However, the 
crystals could not be reproduced, even by microseeding method. 
	
2.3 Analysis of crystal structure of mRuby0.4-3 
         mRuby0.4-3 at pH 8.2 provided clear diffraction patterns with resolution at 2.63Å from X-
ray diffraction experiment, so a dimeric structure model (Fig. 27) including two completely 
identical chains, chain A and chain B, was built based on the data. Similar to K78BoF, it showed 
typical characteristics of GFP-like proteins. The protein also crystallized in monoclinic space 
group C121 but with different unit cell dimensions: a = 108.4Å, b = 77.4Å, c = 66.9Å, α = γ = 
90º, β = 92.1º (Table 14).  
         Although the chromophore was the same as K78BoF, according to electron density maps, 
mRuby0.4-3 chromophores are in the trans state (Fig. 28), rather than the cis state. Meanwhile, 
several potential hydrogen bonds were found between the chromophore and Thr64, Arg71, 
Arg96 with interatomic distances no more than 3.5Å, probably to assist with stabilization of the 
chromophore and red-shift the absorbance. Given that the resolution of the crystal structure was 
not high enough to recognize water molecules, hydrogen bonds between water molecules and 
chromophores, which usually play important roles in protein excitation and red-shift cannot be 
studied here. However, some hints were still able to be seen on the Fo-Fc map. The green 
electron density shown on Fig. 30 suggest that certain atoms exist at those sites, which could 
either be water molecules or free ions from crystallization reagents. To prove that, a crystal 
model with higher resolution will be required.  
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Fig. 27 An overview of crystal structure of mRuby0.4-3 at pH 8.2.  
 
Table 14 Crystallographic data for crystal structure of mRuby0.4-3. 
Space group C121 
Cell dimensions: b (Å) 108.446     
Cell dimensions: b (Å) 77.390     
Cell dimensions: c (Å) 66.851 
Resolution (Å) 66.8-2.63  
Completeness (%) 99.53 
R/Rfree 0.2276/0.3088 
Rmsd bond lengths (Å) 0.0115 
Rmsd bond angles (º) 1.8593 
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A       B  
Fig. 28 Chromophore structures of chain A (B) and chain B (B) for mRuby0.4-3 in electron 
density maps at 1.0 sigma level. 
 
  
Fig. 29 Possible hydrogen bonds (shown in dotted lines) connecting to the chromophore of 
mRuby0.4-3. Bond lengths were measured by PyMOL with unit in Å.  
T64 
R96 
R71 
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Fig. 30 An overview of residues surrounding the mRuby0.4-3 chromophore in electron 
density maps. The figure is a screenshot from COOT with 2Fo-Fc map in blue color and Fo-Fc 
map in green and red. 
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DISCUSSION 
 
1. Optimization of crystallization methods to improve crystal quality  
        To obtain good diffraction patterns from X-ray experiments, a large crystal visible under the 
microscope and a regular shape with certain thickness should be used. In both projects, I tried to 
improve the quality of the crystals through manipulating crystallization conditions. This included 
changing incubating temperature, protein concentration and volume, buffer concentration and 
pH, and salt and precipitant concentration. However, no significant improvement was observed 
visually, and this was further confirmed later by X-ray diffraction results. 
        I also introduced the microseeding method to the optimization experiments, which was 
more effective for K78BoF crystals than mRuby0.4-3 crystals. Moderate improvements on the 
transparency and brightness of K78BoF crystals were observed, though the sizes and the shapes 
did not show significant differences. The resolution of one K78BoF crystal improved from 3.0Å 
to 2.1Å.  
        Actually, there is a chance to further improve the resolution of K78BoF crystals by applying 
the serial seeding method. Serial seeding is an advanced microseeding method that repeatedly 
seeds a new drop made by crystals from the last run of microseeding experiments. It can usually 
help to improve the resolution of crystals in a better manner 75. For example, the resolution of 
ErbB-3-binding protein 1 crystal was increased from 3.2Å to 1.6Å after two runs of serial 
seeding 76. Although wet-lab work for the K78BoF project is finished, this method may be 
employed to improve the quality of mRuby0.4-3 crystals. 
 
2. BoF in crystal structures 
        In spite of boronic acids not being found in nature and the need to be prepared from primary 
sources of boron, they have been proven stable in vivo, nontoxic to cells and are now applied 
commonly in biomedical field studies for developing receptors and sensors for carbohydrates and 
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some small molecules, antimicrobial agents, enzyme inhibitors, and anti-cancer drugs 77. 
However, conjugating it with FPs to develop FP-based biosensors is still a new research field. In 
2012, Wang et al substituted Tyr66 at the chromophore of a GFP with BoF to form a mutant 
UFP-Tyr66pBoPhe with a crystal structure solved at a resolution of 1.24Å, reporting its H2O2-
sensing ability in E. coli 78. In 2013, the Ai group reported the first genetically encoded 
fluorescent probe for peroxynitrite, pnGFP, in which BoF replaced Tyr174 at the chromophore63. 
They further mutated pnGFP into pnGFP1.5 and tried to determine their crystal structures, but no 
crystals were grown 79. In 2016, they developed another peroxynitrite biosensor, K78BoF. 
Unlike pnGFP, K78BoF was derived from RFP rather than GFP, and its BoF mutagenesis 
happened on the β-barrel, instead of at the chromophore. Using the purified protein provided by 
the Ai group, we successfully crystallized K78BoF at pH 6.  
        The electron density map perfectly covers the boron atom and the phenylalanine moiety of 
BoF, but the two hydroxyl groups are excluded by the map, even at 0.5 sigma level (Fig. 20B). 
One explanation for this phenomenon is that inconsistent conformation of BoF existed in the 
protein crystal. In the crystal structure of phenylboronic acid, the weak B-C π-bonding and the 
intermolecular hydrogen bonds stabilized the conformation and made the CBO2 plane coplanar 
to the benzene ring; but asymmetric forces on the two hydroxyl groups might cause a twist 
between two planes 77. In the crystal structure of UFP-Tyr66pBoPhe, the CBO2 plane was rotated 
slightly owing to two hydrogen bonds formed with the nitrogen of His148 and the hydroxyl 
group of Ser205 78. Checking adjacent area of BoF in K78BoF structure model, I could not find 
any residue or water molecule in a reasonable distance (≤ 3.5Å) to form a hydrogen bond. 
Without an outer restriction, the CBO2 planes probably occurred with different angels to the 
benzene ring in different K78BoF molecules. Given that model building is based on all the 
diffraction patterns generated from all molecules shot by X-rays, the inconsistent position of two 
hydroxyl groups on the CBO2 plane may lead to weak X-ray scattering and poor electron density.  
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3. The missing loop in the K78BoF crystal structure 
         A loop from Gly100 to Met114 was found missing during model building after molecular 
replacement. During model refinement, I tried to add the residues back to the model manually, 
but then realized that they could hardly be fitted into the electron density map because the 
electron distribution in the area expected for the loop was weak and diffuse. Also, their inclusion 
in the model increased R factor and R-free factor dramatically. The R factor and R-free factor are 
indicators for the agreement of the experimental crystal data to a structure model, and the lower 
the factors are, the better they agree with each other. The addition of the missing loop to the 
model would reduce the reliability of the crystal structure. Actually, the homologous protein R-
GECO1 also missed a loop in a similar position in its crystal structure 71. The reason for the 
incomplete model may be complicated, but some clues can still be found. 
         The Debye–Waller factor, usually known as the B factor or temperature factor, is an 
indicator for the relative vibrational motion of atoms in a structure. Well-ordered atoms in a 
structure show low B factor, while it increases with enhanced mobility. Testing B factor for the 
model by PyMOL, I found very high B factor for the residues on the terminals of the missing 
loop, as can be seen on Fig. 31. It implies that the missing loop could be so flexible in the 
structure that the electron density cannot be mapped. The result is not surprising if we check the 
components of the loop. The majority of the loop is constructed by glycine, serine and lysine, all 
of which tend to appear frequently in the missing polypeptides of other protein crystal structures 
reported in the Protein Data Bank 80. Easy rotation of their side chains in space is believed to 
increase mobility of the loop, resulting in disorder of the electron distribution on the map.  
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Fig. 31 An overview of K78BoF crystal structure in a B factor version. Red color represents 
high B factor while blue means B factor for the residues is low. 
 
4. Future work for mRuby0.4-3 project 
         Until now, I have obtained two mRuby0.4-3 crystals at pH 8.2 and 9.5 respectively and the 
structure model for the one at pH 8.2 has been built. Reviewing the two goals expected in the 
mRuby0.4-3 project, the first goal on determining its crystal structure was achieved. Yet for the 
second goal, a lot of further work needs to be done in future experiments to analyze the effect of 
pH change on the conformations of the protein.  
         The crystal grown at pH 9.5 was ready for structure model building. However, crystals 
grown in neutral and acidic conditions are still needed. Although the needle-like crystals I grew 
are still far from ideal for X-ray diffraction, the only effective acidic method found in the 
preliminary screening experiment, condition MCSG-1: C2, is a good starting point for further 
optimization. Similar to what we have done to crystallize K78BoF, changing diverse factors of 
R4 
G99 
A115 
T25
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the method in conjugation with the microseeding method may be useful here. The serial seeding 
method is worthy of a trial as well. A situation that could not be understood was the crystals 
grown in condition MCSG-1: C11. Even though the crystals show a perfect shape and size for X-
ray diffraction, no diffraction was observed from shooting. Considering the neutral condition 
obtained for growth of the crystal, we still expect to obtain good diffraction data from this 
method. We will try to conduct serial seeding experiments to look for a breakthrough for this 
crystallization method.   
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CONCLUSION 
 
         In this thesis, X-ray crystallography of two red fluorescent protein variants, K78BoF and 
mRuby0.4-3, were studied to decipher their 3D structures. By using purified protein provided by 
the Ai lab, a monomeric crystal of K78BoF was successfully grown at pH 6 that provided 
resolution of 2.13Å. The structure model showed that its chromophore is formed by Met-Tyr-Gly 
in the cis state. Two water molecules and several residues on the β-barrel interact with the 
chromophore through hydrogen bonds which stabilize the conformation. However, comparing it 
with a homologous variant R-GECO1, we find that the substitution of the unnatural amino acid 
p-boronophenylalanine to Lys prevents the formation of a hydrogen bond between the 
chromophore and Lys, resulting in a conformation change of the phenolic moiety in the 
chromophore. This could be a potential reason for the pH-sensitivity of K78BoF.  
         Protein mRuby0.4-3 was provided as a gene in a plasmid by the Chu lab, so I performed 
protein expression and purification before it was ready for crystallization. Unlike K78BoF, 
crystallization of mRuby0.4-3 showed a strong tolerance to pH change and two dimeric crystals 
grown at pH 8.2 and 9.5 diffracted in X-ray experiments with resolutions of 2.63Å and 2.84Å 
respectively. In the structure model for the crystal at pH 8.2, the chromophore has a trans isomer 
to K78BoF, with several hydrogen bonds linking the residues surrounding it. However, the 
resolution of the crystal was not good enough to recognize water molecules in the electron 
density map, preventing us from deeper structural analysis.  
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